Sanno N, Teramoto A, Matsuno A, Takekoshi S, Itoh J, Osamura R Y
Department of Pathology, Tokai University School of Medicine, Kanagawa, Japan.
Mod Pathol. 1996 May;9(5):526-33.
The pituitary-specific transcriptional factor, Pit-1, is a member of the POU-domain family, which has a role in the development and differentiation of three pituitary cell types: somatotrophs, lactotrophs, and thyrotrophs. Recently, specific DNA-dependent interactions have been observed between Pit-1 and nuclear receptors, including: thyroid hormone receptor; retinoic acid receptor; glucocorticoid receptor; and estrogen receptor (ER). The cooperative interaction between Pit-1 and ER required for prolactin enhancer activity in rat pituitaries has been suggested. We analyzed the expression of Pit-1 messenger ribonucleic acid (mRNA) and ER mRNA in 15 human prolactin-producing adenomas using nonradioisotopic in situ hybridization. Their products were also studied by immunohistochemical analysis. Pit-1 mRNA was detected in 12 (80%) of 15 prolactin-producing adenomas. On the other hand, ER mRNA was detected in 14 (94%) of adenomas studied. mRNAs of Pit-1 and ER were detected more frequently than immunohistochemical expression of their products. By combined in situ hybridization and immunohistochemical examination, Pit-1 mRNA and ER mRNA were often colocalized with prolactin immunoreactivities. The colocalizations of Pit-1 mRNA and ER protein were observed in adenoma cells. The high incidence of the expression of ER mRNA in prolactin-producing adenomas may suggest cooperative interactions between Pit-1 and ER in functional differentiation and development of prolactin-producing adenomas.
垂体特异性转录因子Pit-1是POU结构域家族的成员,在三种垂体细胞类型即生长激素细胞、催乳素细胞和促甲状腺激素细胞的发育与分化中发挥作用。最近,已观察到Pit-1与核受体之间存在特异性的DNA依赖性相互作用,这些核受体包括:甲状腺激素受体;视黄酸受体;糖皮质激素受体;以及雌激素受体(ER)。有人提出,大鼠垂体中催乳素增强子活性所需的Pit-1与ER之间存在协同相互作用。我们使用非放射性原位杂交技术分析了15例人催乳素分泌性腺瘤中Pit-1信使核糖核酸(mRNA)和ER mRNA的表达情况。还通过免疫组织化学分析对它们的产物进行了研究。在15例催乳素分泌性腺瘤中的12例(80%)检测到了Pit-1 mRNA。另一方面,在所研究的腺瘤中,14例(94%)检测到了ER mRNA。Pit-1和ER的mRNA比它们产物的免疫组织化学表达更频繁地被检测到。通过原位杂交和免疫组织化学联合检查发现,Pit-1 mRNA和ER mRNA常与催乳素免疫反应性共定位。在腺瘤细胞中观察到了Pit-1 mRNA和ER蛋白的共定位。催乳素分泌性腺瘤中ER mRNA表达的高发生率可能提示Pit-1与ER在催乳素分泌性腺瘤的功能分化和发育中存在协同相互作用。